Polyploid Giant Cancer Cells: A Distinctive Feature in the Transformation of Epithelial Cells by High-Risk Oncogenic HCMV Strains.
Georges HerbeinRanim El BabaPublished in: Viruses (2024)
Human cytomegalovirus (HCMV) infection is common in tumor tissues across different types of cancer. While HCMV has not been recognized as a cancer-causing virus, numerous studies hint at its potential role in cancer development where its presence in various cancers corresponds with the hallmarks of cancer. Herein, we discuss and demonstrate that high-risk HCMV-DB and BL strains have the potential to trigger transformation in epithelial cells, including human mammary epithelial cells (HMECs), ovarian epithelial cells (OECs), and prostate epithelial cells (PECs), through the generation of polyploid giant cancer cells (PGCCs). A discussion is provided on how HCMV infection creates a cellular environment that promotes oncogenesis, supporting the continuous growth of CMV-transformed cells. The aforementioned transformed cells, named CTH, CTO, and CTP cells, underwent giant cell cycling with PGCC generation parallel to dedifferentiation, displaying stem-like characteristics and an epithelial-mesenchymal transition (EMT) phenotype. Furthermore, we propose that giant cell cycling through PGCCs, increased EZH2 expression, EMT, and the acquisition of malignant traits represent a deleterious response to the cellular stress induced by high-risk oncogenic HCMV strains, the latter being the origin of the transformation process in epithelial cells upon HCMV infection and leading to adenocarcinoma of poor prognosis.
Keyphrases
- poor prognosis
- epithelial mesenchymal transition
- papillary thyroid
- induced apoptosis
- giant cell
- squamous cell
- escherichia coli
- cell cycle arrest
- long non coding rna
- endothelial cells
- prostate cancer
- squamous cell carcinoma
- gene expression
- endoplasmic reticulum stress
- cell death
- machine learning
- oxidative stress
- dna methylation
- high intensity
- radiation therapy
- epstein barr virus
- induced pluripotent stem cells
- genome wide
- binding protein
- neural network